The frequency of musculoskeletal manifestations among psoriatic patients | ||
| Benha Journal of Applied Sciences | ||
| Article 33, Volume 6, Issue 5, September 2021, Pages 205-207 PDF (255.84 K) | ||
| Document Type: Original Research Papers | ||
| DOI: 10.21608/bjas.2021.199490 | ||
| Authors | ||
| A.I. Fouda1; R.M. Fawzy2; A.M. Shoshan2; G.A. Hammad2; A.I. El-Taweel2 | ||
| 1Rheumatology, Rehabilitation and Physical medicine Dept., Faculty of Medicine, Benha Univ., Benha, Egyp | ||
| 2Rheumatology, Rehabilitation and Physical medicine Dept., Faculty of Medicine, Benha Univ., Benha, Egypt | ||
| Abstract | ||
| Background: psoriasis (Pso) is a prototype of Th1 proinflammatory cytokines mediated by an immunological dysfunction. It is usually seen as inflammatory skin disease with far-reaching systemic consequences of uncertain aetiology. There is increasing evidence of the seriousness of psoriatic skin disease as a significant danger of developing outbreaks of extracutaneous diseases and of the greater frequency of co-morbid illness linked with cardiometabolic dysfunction and Psoriatic Arthritis (PsA). Methods: 200 psoriatic patients were included in this research. Patients were split into two groups depending on whether there was bursitis or not. Patients were tested and examined in history. Results: Bursitis patients had a higher rate of psoriatic arthritis, enthesitis, heel condition, cardiovascular illness, serum higher uric acid, longer duration of psoriasis disease than bursitis-free group. Conclusions: Longer duration of psoriasis, leading to greater cardiovascular and musculoskeletal symptoms. | ||
| Keywords | ||
| Psoriasis; Psoriatic arthritis; Bursitis | ||
|
Statistics Article View: 191 PDF Download: 389 |
||
